Publications by authors named "Benedetta Bonora"

Claim this Profile
T
The importance of treatment sequencing with SGLT2 inhibitors and GLP-1 receptor agonists combination for kidney function preservation in type 2 diabetes.
Mario Luca Morieri, Monica Vedovato, Benedetta Maria Bonora, Paola Fioretto, Gian Paolo Fadini

Diabetes Obes Metab· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term effects of adding an SGLT-2 inhibitor to insulin therapy in patients with type 1 diabetes. An observational study and systematic review of real-world evidence.
Alberto Maran, Federico Boscari, Carlo Fagarazzi, Maria Cristina Crepaldi, Monica Vedovato, Benedetta Maria Bonora

J Endocrinol Invest· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Effectiveness of Once-Weekly Semaglutide in Patients With Type 2 Diabetes Previously Treated With Insulin. A Multicentre Real-World Study.
Benedetta Maria Bonora, Andrea Giaccari, Agostino Consoli, Fabio Broglio, Angelo Avogaro

Diabetes Metab Res Rev· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral or injectable semaglutide for the management of type 2 diabetes in routine care: A multicentre observational study comparing matched cohorts.
Gian Paolo Fadini, Benedetta Maria Bonora, Mariangela Ghiani, Roberto Anichini, Elena Melchionda

Diabetes Obes Metab· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating haematopoietic stem cells and long-term outcomes of COVID-19.
Benedetta Maria Bonora, Marella Marassi, Paola Fogar, Jenny Zuin, Roberta Cappellari

Eur J Clin Invest· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved prediction of long-term kidney outcomes in people with type 2 diabetes by levels of circulating haematopoietic stem/progenitor cells.
Benedetta Maria Bonora, Mario Luca Morieri, Marella Marassi, Roberta Cappellari, Angelo Avogaro

Diabetologia· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Ketosis-prone Diabetes and Hypogonadism: A New Clinical Association to be Aware of ?
Andrea Graziani, Riccardo Maria Pollis, Benedetta Maria Bonora, Carla Scaroni, Chiara Sabbadin

Endocr Metab Immune Disord Drug Targets· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathophysiological basis of the cardiological benefits of SGLT-2 inhibitors: a narrative review.
Cristina Panico, Benedetta Bonora, Antonella Camera, Nino Cristiano Chilelli, Giuliana Da Prato

Cardiovasc Diabetol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glycaemic Control Achieves Sustained Increases of Circulating Endothelial Progenitor Cells in Patients Hospitalized for Decompensated Diabetes: An Observational Study.
Benedetta Maria Bonora, Roberta Cappellari, Marco Grasso, Marta Mazzucato, Marianna D'Anna

Diabetes Ther· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hematopoietic and Nonhematopoietic Differentially Regulates Stem Cell Traffic and Vascular Response to Ischemia in Diabetes.
Mattia Albiero, Marianna D'Anna, Benedetta Maria Bonora, Gaia Zuccolotto, Antonio Rosato

Antioxid Redox Signal· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hyperglycemia, Reduced Hematopoietic Stem Cells, and Outcome of COVID-19.
Benedetta Maria Bonora, Paola Fogar, Jenny Zuin, Daniele Falaguasta, Roberta Cappellari

Diabetes· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance of intermittently scanned continuous glucose monitoring systems in people with type 1 diabetes: A pooled analysis.
Othmar Moser, Christoph Sternad, Max L Eckstein, Agnieszka Szadkowska, Arkadiusz Michalak, Benedetta Maria Bonora

Diabetes Obes Metab· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hematopoietic progenitor cell liabilities and alarmins S100A8/A9-related inflammaging associate with frailty and predict poor cardiovascular outcomes in older adults.
Benedetta Maria Bonora, Maria Teresa Palano, Gianluca Testa, Gian Paolo Fadini, Elena Sangalli

Aging Cell· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to Chia Siang Kow and colleagues.
Angelo Avogaro, Benedetta Maria Bonora, Gian Paolo Fadini

Acta Diabetol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Managing diabetes in diabetic patients with COVID: where do we start from?
Angelo Avogaro, Benedetta Bonora, Gian Paolo Fadini

Acta Diabetol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fenofibrate increases circulating haematopoietic stem cells in people with diabetic retinopathy: a randomised, placebo-controlled trial.
Benedetta Maria Bonora, Mattia Albiero, Mario Luca Morieri, Roberta Cappellari, Francesco Ivan Amendolagine

Diabetologia· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of patients with type 2 diabetes treated with SGLT-2 inhibitors versus DPP-4 inhibitors. An Italian real-world study in the context of other observational studies.
Enrico Longato, Benedetta Maria Bonora, Barbara Di Camillo, Giovanni Sparacino, Lara Tramontan

Diabetes Res Clin Pract· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deintensification of basal-bolus insulin after initiation of GLP-1RA in patients with type 2 diabetes under routine care.
Benedetta Maria Bonora, Mauro Rigato, Vera Frison, Michele D'Ambrosio, Federica Tadiotto

Diabetes Res Clin Pract· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SGLT-2 inhibitors and atrial fibrillation in the Food and Drug Administration adverse event reporting system.
Benedetta Maria Bonora, Emanuel Raschi, Angelo Avogaro, Gian Paolo Fadini

Cardiovasc Diabetol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Toll of Lockdown Against COVID-19 on Diabetes Outpatient Care: Analysis From an Outbreak Area in Northeast Italy.
Benedetta Maria Bonora, Mario Luca Morieri, Angelo Avogaro, Gian Paolo Fadini

Diabetes Care· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diabetes pharmacotherapy and circulating stem/progenitor cells. State of the art and evidence gaps.
Mattia Albiero, Benedetta Maria Bonora, Gian Paolo Fadini

Curr Opin Pharmacol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exposure to dipeptidyl-peptidase 4 inhibitors and the risk of pneumonia among people with type 2 diabetes: Retrospective cohort study and meta-analysis.
Mario Luca Morieri, Benedetta Maria Bonora, Enrico Longato, Barbara Di Camilo, Giovanni Sparacino

Diabetes Obes Metab· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deterioration.
Gian Paolo Fadini, Mario Luca Morieri, Federico Boscari, Paola Fioretto, Alberto Maran, Benedetta Maria Bonora

Diabetes Res Clin Pract· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hyperglycemia, glucocorticoid therapy, and outcome of COVID-19.
Mario Luca Morieri, Gian Paolo Fadini, Federico Boscari, Paola Fioretto, Alberto Maran, Benedetta Maria Bonora

Diabetes Res Clin Pract· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stem cell mobilization with plerixafor and healing of diabetic ischemic wounds: A phase IIa, randomized, double-blind, placebo-controlled trial.
Benedetta Maria Bonora, Roberta Cappellari, Marta Mazzucato, Mauro Rigato, Marco Grasso

Stem Cells Transl Med· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis